Table 1.

Kidney and liver function tests

	Creatinine	Urea	ALT	AST
Control	0.4483 ± 0.039b	44.94 ± 0.065b	45.22 ± 0.685b	79.8 ± 0.2b
	SEM ± 0.022	SEM ± 0.037	SEM ± 0.306	SEM ± 0.089
Cisplatin	0.974 ± 0.024a	145.5 ± 0.51a	88.91 ± 0.91a	145.8 ± 0.55a
	SEM ± 0.014	SEM ± 0.28	SEM ± 0.407	SEM ± 0.246
SH 100	0.4967 ± 0.025b	33.88 ± 0.12a,b	39.99 ± 0.99b	74.5 ± 0.5b
	SEM ± 0.013	SEM ± 0.069	SEM ± 0.44	SEM ± 0.226
SH 50	0.5077 ± 0.026b	30.65 ± 0.65a,b	41.65 ± 0.65b	86.8 ± 0.2a,b
	SEM ± 0.015	SEM ± 0.37	SEM ± 0.290	SEM ± 0.083
SP 100	0.5543 ± 0.038b	32.7 ± 0.69a,b	40.73 ± 0.725b	76.87 ± 0.41b
	SEM ± 0.022	SEM ± 0.40	SEM ± 0.324	SEM ± 0.21
SP 50	0.5073 ± 0.015b	31.78 ± 0.71a,b	43.5 ± 0.51b	86.4 ± 0.56a,b
	SEM ± 0.018	SEM ± 0.44	SEM ± 0.223	SEM ± 0.25

Data is expressed as mean ± SD, and Standard error of the mean SEM

^aSignificant compared to the control group; p-value < 0.0001. ^bSignificant compared to the Cisplatin model group; p-value < 0.0001